Is subclinical hyperthyroidism a risk factor for poor functional outcome after ischemic stroke?
Subclinical hyperthyroidism is a risk factor for poor outcome 3 months after ischemic stroke.
Rhodomyrtone enhanced the expression of pattern recognition receptors by monocytes in response to MRSA. Increased expression of these receptors might improve MRSA clearance by modulating pro- and anti-inflammatory cytokine responses.